drugset / Trial / NCT04315454

Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery

NCT04315454

Phase 1 Unknown 30 enrolled South Egypt Cancer Institute
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

To study analgesic efficacy \&safety of bilateral erector spinae block for upper abdominal cancer surgery as apart of multimodal analgesia.

Timeline

Start
2019-06-01
Primary completion
2020-12
Completion
2021-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 0.25 % Other
Subject Levobupivacaine Other / unclassified 20 mg Other

Indications

No indication recorded.